Table S4. Resistance and sensitivity rates of non-fermentative gram-negative bacilli to antimicrobial agents from major hospitals — China, 2022 (%).
| Antimicrobial agent |
P. aeruginosa
( n=27,257) |
Acinetobacter
spp.
( n=29,069) |
S.maltophilia
( n=9,097) |
B.cepacia
( n=2,444) |
|||||||
| R | S | R | S | R | S | R | S | ||||
| Abbreviation: R=resistant; S=susceptible; NA=not available. | |||||||||||
| Amikacin | 3.5 | 95.4 | 51.1 | 47.6 | NA | NA | NA | NA | |||
| Gentamicin | 7.0 | 89.7 | 61.0 | 35.4 | NA | NA | NA | NA | |||
| Imipenem | 22.1 | 75.5 | 65.8 | 33.7 | NA | NA | NA | NA | |||
| Meropenem | 17.6 | 77.9 | 66.6 | 32.8 | NA | NA | 10.7 | 81.2 | |||
| Cefepime | 9.4 | 82.3 | 61.6 | 33.0 | NA | NA | NA | NA | |||
| Ceftazidime | 14.0 | 80.9 | 66.0 | 32.1 | 36 | 57.1 | 6.8 | 90.2 | |||
| Ceftazidime-avibactam | 7.2 | 92.8 | 81.3 | 18.7 | NA | NA | NA | NA | |||
| Cefoperazone-sulbactam | 13.8 | 75.2 | 52.1 | 36.5 | NA | NA | NA | NA | |||
| Aztreonam | 20.1 | 64.4 | NA | NA | NA | NA | NA | NA | |||
| Piperacillin | 16.2 | 74.8 | 67.9 | 26.6 | NA | NA | NA | NA | |||
| Piperacillin-tazobactam | 12.0 | 78.6 | 67.6 | 30.5 | NA | NA | NA | NA | |||
| Ampicillin-sulbactam | NA | 2.0 | 60.8 | 33.5 | NA | NA | NA | NA | |||
| Ciprofloxacin | 14.5 | 78.8 | 66.2 | 33.1 | NA | NA | NA | NA | |||
| Levofloxacin | 20.1 | 72.1 | 54.3 | 35 | 8.7 | 88.3 | 19.0 | 70.3 | |||
| Trimethoprim-sulfamethoxazole | NA | 14.2 | 49.9 | 49.8 | 6.4 | 93.1 | 4.3 | 94.2 | |||
| Colistin | 1.7 | 98.3 | 1.6 | 98.4 | NA | NA | NA | NA | |||
| Polymixin B | 0.5 | 99.5 | 2.3 | 97.7 | NA | NA | NA | NA | |||
| Tigecycline | NA | NA | 2.2 | 89.5 | NA | NA | NA | NA | |||
| Minocycline | NA | NA | 15.6 | 61.5 | 1.0 | 96.3 | 3.6 | 90.0 | |||
| Chloramphenicol | 93.0 | 4.4 | NA | NA | 17.3 | 63.9 | 11.9 | 78.4 | |||